Investing.com – IDEXX Labs NASDAQ: reported Wednesday that the first quarter of fiscal 2009 was disappointing. The revenue fell below analysts’ expectations.

IDEXX Labs posted earnings per share in the range of $2.24 to $836.55M on revenue. Investing.com polled analysts to predict EPS of 2.26 on revenues of $839.47M.

IDEXX Labs shares fell 6% over the first of the year but are down 38.29% from their 52-week high $706.51, which was set on August 4, 2020. They are outperforming the S&P 500 which is down 12.39% from the start of the year.

IDEXX Labs is following other important earnings from the Healthcare sector this month

IDEXX Labs’s report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.

UnitedHealth beat all expectations with a first quarter earnings per share of $5.49 on $80.15B in revenue, as compared to EPS forecasts of $5.36 for $78.73B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar